"anat Chattopadhyay is Executive Vice President of Merck and President of the Merck Manufacturing Division, with responsibility for Merck’s worldwide manufacturing operations supporting global sales revenues of approximately 40 billion USD. Merck is known as MSD outside of the U.S. and Canada...Outside Merck, Mr. Chattopadhyay serves on the Board of Directors of Hilleman Laboratories, an equal joint-venture partnership formed between Merck and Wellcome Trust, a global charitable foundation dedicated to human and animal health. He is also a member of the Advisory Board of USA-India Chamber of Commerce.
"Before joining Merck in November 2009, Mr. Chattopadhyay worked for Wyeth Pharmaceuticals as Senior Vice President, New Products & Process Development. A graduate Chemical Engineer and a post-graduate Industrial Engineer from India, he started his career with Hoechst Pharmaceuticals in 1983 and worked in many senior leadership assignments in 5 countries across 3 continents, rising to the level of Senior Vice President, Product Development & Supply at Aventis where he led global supply chain, including new product commercialization, technology and engineering." 
- Director, Hilleman Laboratories
Resources and articles
- Board, Hilleman Laboratories, accessed April 23, 2020.